id,group_id,source,exact,prefix,suffix,anno_type,position_type,start,end,tags,all,origin_tags,comment,user,title,created
zmnC4rQKEem-pLdFF_kdCg,jgraPEon,https://europepmc.org/articles/PMC5395742/,LATS1 or pYAPS127 in 90 paraffin-embedded surgical specimens of HCC, to determine the expression of , from Nanfang Hospital. The expr,TextQuoteSelector,TextPositionSelector,49213,49280,NGD,no,NGD,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:16:51.517747+00:00
zYN6pK0zEems68dQW2QcyA,jgraPEon,https://europepmc.org/articles/PMC5395742/,humans,hat are highly conserved across ,", mice, and rats, so-called ultr",TextQuoteSelector,TextPositionSelector,51814,51820,CRT_OG,no,CRT_OG,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:22:41.181901+00:00
zY2Oaq0xEemYPW-CbDh23A,jgraPEon,https://europepmc.org/articles/PMC5395742/,BALB/c nude mice,ittee of Nanfang Hospital. Male ," (age, 4–6 weeks; Guangdong Medi",TextQuoteSelector,TextPositionSelector,21460,21476,WS_OG,no,WS_OG,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:08:22.100577+00:00
z9KJ8q00Eemwhrv0nwQRkQ,jgraPEon,https://europepmc.org/articles/PMC5395742/,pepsin ,", HCC samples were treated with ",for 10 min at room temperature a,TextQuoteSelector,TextPositionSelector,19318,19325,MIS_GP,no,MIS_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:29:54.591416+00:00
z5jSkK0yEemwKOdeEFhp1w,jgraPEon,https://europepmc.org/articles/PMC5395742/,hepatocarcinogenesis ,ression plays critical roles in ,and metastasis [13–15]. Moreover,TextQuoteSelector,TextPositionSelector,13749,13770,WT_DS,no,[WT_DS],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:15:35.083769+00:00
ycuXuq00Eemolo-3RylI5A,jgraPEon,https://europepmc.org/articles/PMC5395742/,kinase ,y is a highly conserved protein ,chain that plays a pivotal role ,TextQuoteSelector,TextPositionSelector,15040,15047,MIS_GP,yes,[MIS_GP][ALL],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:29:44.401514+00:00
yJps9q0yEemnna9mlNUg4g,jgraPEon,https://europepmc.org/articles/PMC5395742/,CRL4,", an E3 ubiquitin ligase of the ", complex [42]. CUL4A is a core c,TextQuoteSelector,TextPositionSelector,54799,54803,CRT_GP,yes,[CRT_GP][ALL],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:15:23.283860+00:00
xdCj4K0zEemZxafs61RQ4A,jgraPEon,https://europepmc.org/articles/PMC5395742/,polyubiquitin ,eus to the cytoplasm to disrupt ,"chains, which activates the Hipp",TextQuoteSelector,TextPositionSelector,46523,46537,WT_GP,no,[WT_GP],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:22:27.963221+00:00
x97uArQKEem47j9oWII74g,jgraPEon,https://europepmc.org/articles/PMC5395742/,"LATS1, and pYAPS127 expression by ISH and IHC in paraffin-embedded samples from patients with HCC ","died correlations among uc.134, ",(Fig. 6a). IHC analysis was used,TextQuoteSelector,TextPositionSelector,49051,49149,NGD,no,NGD,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:16:40.387777+00:00
wYf5VLQKEemrywfEMFpClg,jgraPEon,https://europepmc.org/articles/PMC5395742/,tumor model by injecting the indicated cells into the tail veins of nude,generated a tail vein xenograft , mice. At the end of the experim,TextQuoteSelector,TextPositionSelector,36416,36488,NGD,no,NGD,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:16:29.847582+00:00
w1uiqq0yEemcVPvPtOIrGg,jgraPEon,https://europepmc.org/articles/PMC5395742/,CRL4, kinase signaling by inhibiting ,"DCAF1, an E3 ubiquitin ligase of",TextQuoteSelector,TextPositionSelector,54758,54762,MIS_GP,yes,[MIS_GP][ALL],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:15:14.698328+00:00
vKb6LK0yEemS_1eR7f0POQ,jgraPEon,https://europepmc.org/articles/PMC5395742/, tumorigenesis," Hippo pathway, which suppresses"," and stem cell differentiation, ",TextQuoteSelector,TextPositionSelector,42564,42578,WT_DS,yes,[WT_DS][ALL],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:15:03.254076+00:00
uiMBNK0xEemnG2fSsCmJLA,jgraPEon,https://europepmc.org/articles/PMC5395742/,mice, left flanks or right flanks of ,". After 4 weeks, the tumors were",TextQuoteSelector,TextPositionSelector,21840,21844,CRT_OG,yes,[CRT_OG][ALL],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:07:49.559637+00:00
u2Ap_LQKEem0DyPBIHgrzw,jgraPEon,https://europepmc.org/articles/PMC5395742/,tumor model by subcutaneously injecting HCC cells in which uc.134 was stably overexpressed or knocked down into the flanks of nude ,"udies, we generated a xenograft ",mice. The overexpression of uc.1,TextQuoteSelector,TextPositionSelector,35533,35664,NGD,no,NGD,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:16:19.538468+00:00
tsnq9q0yEemcU4dPzLmBNw,jgraPEon,https://europepmc.org/articles/PMC5395742/,RNP,at uc.134 and CUL4A can form an , complex in vitro. Previous stud,TextQuoteSelector,TextPositionSelector,38094,38097,WT_GP,yes,[WT_GP][ALL],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:14:53.651786+00:00
sDpllK0yEembHtt0PdpHQw,jgraPEon,https://europepmc.org/articles/PMC5395742/,cell invasion,tion of uc.134 markedly reduced , compared with control cells (Fi,TextQuoteSelector,TextPositionSelector,34010,34023,WT_DS,yes,[WT_DS][ALL],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:14:42.464738+00:00
s8aC8K0zEemaC59pR7PZJA,jgraPEon,https://europepmc.org/articles/PMC5395742/,cysteine-rich angiogenic inducer 61,"ls of YAP target genes, such as "," (CYR61), c-Myc, drosophila inhi",TextQuoteSelector,TextPositionSelector,45235,45270,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:21:57.966345+00:00
raXpEq0xEemZtYNeXTUztg,jgraPEon,https://europepmc.org/articles/PMC5395742/,human,", Rockville, MD). The Arraystar ", lncRNA microarray is designed f,TextQuoteSelector,TextPositionSelector,17197,17202,CRT_OG,yes,[CRT_OG][ALL],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:07:28.680222+00:00
qvaF-K0zEem6y_-98AmDHA,jgraPEon,https://europepmc.org/articles/PMC5395742/,MST1,"ignaling pathway, such as Mob1, ","/2, LATS1, and YAP, whereas the ",TextQuoteSelector,TextPositionSelector,45158,45162,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:21:42.881858+00:00
qWUifK0yEemaquspoxFiBA,jgraPEon,https://europepmc.org/articles/PMC5395742/,IgG ,nput controls and normal rabbit ,controls were assayed simultaneo,TextQuoteSelector,TextPositionSelector,24532,24536,MIS_GP,yes,[MIS_GP][ALL],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:14:31.011066+00:00
qI8d2K00EemcXYfL24aBtA,jgraPEon,https://europepmc.org/articles/PMC5395742/, Dlx-6,nic region between the Dlx-5 and," genes, activates transcriptiona",TextQuoteSelector,TextPositionSelector,14491,14497,MIS_GP,no,MIS_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:28:48.549874+00:00
q5r_dK00EemLFncJZfLpMQ,jgraPEon,https://europepmc.org/articles/PMC5395742/,Dlx-2,ty by directly interacting with , in a target- and homeodomain-sp,TextQuoteSelector,TextPositionSelector,14569,14574,MIS_GP,no,MIS_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:28:53.834266+00:00
pl1Ufq0xEemYhZPflBnjEg,jgraPEon,https://europepmc.org/articles/PMC5395742/,tumors,"nks of mice. After 4 weeks, the ", were embedded in paraffin for I,TextQuoteSelector,TextPositionSelector,21865,21871,CRT_DS,yes,[CRT_DS][ALL],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:07:16.596581+00:00
pghR3q0zEem6GfeidH1NCg,jgraPEon,https://europepmc.org/articles/PMC5395742/,Mob1,"ippo signaling pathway, such as ",", MST1/2, LATS1, and YAP, wherea",TextQuoteSelector,TextPositionSelector,45152,45156,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:21:34.761470+00:00
oQ_JAK0zEemZbG880Nz5Ag,jgraPEon,https://europepmc.org/articles/PMC5395742/,ubiquitin protein ligase, uc.134 significantly repressed , and RNA polymerase activity com,TextQuoteSelector,TextPositionSelector,41748,41772,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:21:26.489092+00:00
o-4Ieq00EemfeXfR2aGS5A,jgraPEon,https://europepmc.org/articles/PMC5395742/,Dlx-5 ,e intergenic region between the ,"and Dlx-6 genes, activates trans",TextQuoteSelector,TextPositionSelector,14482,14488,MIS_GP,no,MIS_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:28:40.855330+00:00
npiR3rRUEemQoRvsIsIArA,jgraPEon,https://europepmc.org/articles/PMC5395742/,peroxidase, by incubation with horseradish , (HRP)-conjugated anti-DIG antib,TextQuoteSelector,TextPositionSelector,20074,20084,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T12:05:13.995213+00:00
nEbNHK0xEem6Cj_uUSVzLw,jgraPEon,https://europepmc.org/articles/PMC5395742/, cancer ,mic regions that are involved in,and differentially expressed in ,TextQuoteSelector,TextPositionSelector,51943,51951,CRT_DS,yes,[CRT_DS][ALL],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:06:59.422587+00:00
n3IiOK0yEemQrvP4JKS7fQ,jgraPEon,https://europepmc.org/articles/PMC5395742/,rabbit,-PCR. Input controls and normal , IgG controls were assayed simul,TextQuoteSelector,TextPositionSelector,24525,24531,CRT_OG,yes,[CRT_OG][ALL],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:14:14.469571+00:00
mwLTBK0zEemXjadCQ_kAgA,jgraPEon,https://europepmc.org/articles/PMC5395742/,colon cancer ,A to promote the development of ,[33]. Although CUL4A is predomin,TextQuoteSelector,TextPositionSelector,40812,40825,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:21:16.355285+00:00
mQDr3K0yEemXiVdiJh32Tg,jgraPEon,https://europepmc.org/articles/PMC5395742/, MEG3,"he degradation of NF90 [19], and", is a predictive biomarker for m,TextQuoteSelector,TextPositionSelector,14176,14181,CRT_GP,yes,[CRT_GP][ALL],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:14:03.568446+00:00
lD1iYK0yEemigo-tDAazVQ,jgraPEon,https://europepmc.org/articles/PMC5395742/,malignancies,(HCC) is one of the most common ," worldwide, and tumor recurrence",TextQuoteSelector,TextPositionSelector,9846,9858,WT_DS,yes,[WT_DS][ALL],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:13:55.563321+00:00
l1T6hLRUEemi1Uexgfr0zA,jgraPEon,https://europepmc.org/articles/PMC5395742/, horseradish, was detected by incubation with, peroxidase (HRP)-conjugated ant,TextQuoteSelector,TextPositionSelector,20061,20073,CRT_OG,no,CRT_OG,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T12:05:01.691917+00:00
kpfsuK0zEemihvMf6NN_nw,jgraPEon,https://europepmc.org/articles/PMC5395742/, DICER1,g triggers the ubiquitination of, in cytoplasm by CUL4A to promot,TextQuoteSelector,TextPositionSelector,40752,40759,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:21:02.371821+00:00
kgXJAq02Eem6JKfS_VgCPQ,jgraPEon,https://europepmc.org/articles/PMC5395742/,threonine kinase ,"pies [41]. Moreover, the serine/",LATS1 is a core kinase of Hippo ,TextQuoteSelector,TextPositionSelector,54509,54526,MIS_GP,no,MIS_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:42:29.798298+00:00
k_j84K00EemqnVcgPqByig,jgraPEon,https://europepmc.org/articles/PMC5395742/,Hippo ,"“driver oncogene” [26], and the ",pathway is a highly conserved pr,TextQuoteSelector,TextPositionSelector,14996,15002,MIS_GP,yes,[MIS_GP][ALL],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:28:13.876777+00:00
jQRbaq0zEemUWPfbllnnIA,jgraPEon,https://europepmc.org/articles/PMC5395742/,Jak,shown that inflammation-induced ,-STAT3 signaling triggers the ub,TextQuoteSelector,TextPositionSelector,40702,40705,MIS_GP,yes,[MIS_GP][ALL],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:20:52.941034+00:00
indlsq00EemwMZvSMuylZA,jgraPEon,https://europepmc.org/articles/PMC5395742/,KI67 ,"s: ISH staining, middle panels: ","staining, lower panels: HE stain",TextQuoteSelector,TextPositionSelector,63248,63253,MIS_GP,yes,[MIS_GP][ALL],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:27:58.258991+00:00
i-1Jgq0xEembGXdvfXcspQ,jgraPEon,https://europepmc.org/articles/PMC5395742/,Tumor ,cm)0.0420.487 <51138132 ≥5574017,number4.0440.032 Single1459946 M,TextQuoteSelector,TextPositionSelector,32500,32506,MIS_DS,yes,[MIS_DS][ALL],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:06:32.197219+00:00
g_SKaK0zEemfcx_FhcBQ4g,jgraPEon,https://europepmc.org/articles/PMC5395742/,STAT3,n that inflammation-induced Jak-, signaling triggers the ubiquiti,TextQuoteSelector,TextPositionSelector,40706,40711,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:20:37.844236+00:00
g6rI0q00Eems86_2hgRmhQ,jgraPEon,https://europepmc.org/articles/PMC5395742/,HOXA11,by qRT-PCR in HCC cells. (A) nc-,-86 (B) ENST00000426547 (C) ENST,TextQuoteSelector,TextPositionSelector,61314,61320,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:27:46.784652+00:00
fon_kq0xEemZ_s85HxfNHQ,jgraPEon,https://europepmc.org/articles/PMC5395742/,tumor,"mon malignancies worldwide, and ", recurrence and metastasis are m,TextQuoteSelector,TextPositionSelector,9874,9879,CRT_DS,yes,[CRT_DS][ALL],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:06:09.623516+00:00
fOHreq00Eem24rN3P5yEJw,jgraPEon,https://europepmc.org/articles/PMC5395742/,HDAC3,CC [20]. Histone deacetylase 3 (,) is involved in the suppression,TextQuoteSelector,TextPositionSelector,58789,58794,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:27:35.446048+00:00
eJsrxq00EemZyONsz6DtEQ,jgraPEon,https://europepmc.org/articles/PMC5395742/, Histone deacetylase 3,butes to the growth of HCC [20]., (HDAC3) is involved in the supp,TextQuoteSelector,TextPositionSelector,58765,58787,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:27:28.187117+00:00
eCiUcq0zEemnozt_x2uTwA,jgraPEon,https://europepmc.org/articles/PMC5395742/, p21,"itinated by CUL4A including p53,",", p27, DICER, and LATS1 [32]. Pr",TextQuoteSelector,TextPositionSelector,40614,40618,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:20:17.917369+00:00
e-GBUK0zEemnpCtqqSdygw,jgraPEon,https://europepmc.org/articles/PMC5395742/,p27,"ed by CUL4A including p53, p21, ",", DICER, and LATS1 [32]. Previou",TextQuoteSelector,TextPositionSelector,40620,40623,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:20:24.052891+00:00
dOLWsq0xEem2uStPBslJ4g,jgraPEon,https://europepmc.org/articles/PMC5395742/,LATS1,UL4A-mediated ubiquitination of ,"Wen Ni,1 Yuqin Zhang,1 Zetao Zha",TextQuoteSelector,TextPositionSelector,7125,7130,CRT_GP,yes,[CRT_GP][ALL],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:05:53.352704+00:00
dCo-eq0zEemnLhuxc1eYkw,jgraPEon,https://europepmc.org/articles/PMC5395742/, p53,ubiquitinated by CUL4A including,", p21, p27, DICER, and LATS1 [32",TextQuoteSelector,TextPositionSelector,40609,40613,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:20:11.119928+00:00
cN9grK0yEemR61seBYVFHA,jgraPEon,https://europepmc.org/articles/PMC5395742/, HBV infection,uc.134 in HCC may be mediated by," at the transcriptional level, p",TextQuoteSelector,TextPositionSelector,58925,58939,WS_DS,no,WS_DS,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:12:56.229976+00:00
biEJQK00EemwMD8Z9Ev9qQ,jgraPEon,https://europepmc.org/articles/PMC5395742/,caspases , directly binds to and inhibits ,to suppress apoptosis. Activatio,TextQuoteSelector,TextPositionSelector,56978,56987,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:27:10.729045+00:00
bXPgwq0zEemXjONwofh5sA,jgraPEon,https://europepmc.org/articles/PMC5395742/, AFP,ative483414 Positive1198435Serum, (ng/ml)3.8850.037 <25674225 ≥25,TextQuoteSelector,TextPositionSelector,32413,32417,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:19:59.960668+00:00
bAaSQK0xEemj_2sfo4PbyA,jgraPEon,https://europepmc.org/articles/PMC5395742/,CUL4A,tion and invasion by inhibiting , to ubiquitinate LATS1 and incre,TextQuoteSelector,TextPositionSelector,16339,16344,CRT_GP,yes,[CRT_GP][ALL],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:05:38.469500+00:00
aCSGhK00Eems8vt0UpjPsQ,jgraPEon,https://europepmc.org/articles/PMC5395742/, c-Abl,ty of c-Myc via interaction with, in HCC [45]. diap1 directly bin,TextQuoteSelector,TextPositionSelector,56921,56927,WS_GP,no,WS_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:27:00.677018+00:00
a8AJWq0yEem22CNFF_xwpg,jgraPEon,https://europepmc.org/articles/PMC5395742/,hepatitis C virus infection,"virus (HBV) infection, although ", and exposure to toxic chemical ,TextQuoteSelector,TextPositionSelector,58517,58544,WS_DS,no,WS_DS,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:12:47.631340+00:00
_hx80q00EemZyvuMZMi_1Q,jgraPEon,https://europepmc.org/articles/PMC5395742/,Merlin ,n. A previous study showed that ,activates Hippo kinase signaling,TextQuoteSelector,TextPositionSelector,54704,54711,MIS_GP,no,MIS_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:31:12.169549+00:00
_H7erK0zEem4NgOXKjdGEw,jgraPEon,https://europepmc.org/articles/PMC5395742/,TGFβ,"signaling pathways, such as the ","/SMAD, WNT/β-catenin, PI3-kinase",TextQuoteSelector,TextPositionSelector,54296,54300,MIS_GP,no,MIS_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:24:00.053197+00:00
_DBk7LQKEem8s3_1s8ksLQ,jgraPEon,https://europepmc.org/articles/PMC5395742/, LATS1 and CUL4A protein in HCC,e interaction between endogenous, cells (Fig. 4c). Although a lar,TextQuoteSelector,TextPositionSelector,42397,42428,YGD,no,YGD,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:18:08.226949+00:00
ZhBfBK0zEemYRv8mSxccww,jgraPEon,https://europepmc.org/articles/PMC5395742/, RSRC1,ated in the intron region of the, gene (Fig. 1b) exhibited the gr,TextQuoteSelector,TextPositionSelector,29610,29616,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:19:47.588441+00:00
ZCWCIK0xEemo3AMeVfTWJA,jgraPEon,https://europepmc.org/articles/PMC5395742/,Hepatocellular carcinoma," LATS1, pYAPS127Go to:Background", (HCC) is one of the most common,TextQuoteSelector,TextPositionSelector,12610,12634,MIS_DS,no,MIS_DS,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:05:25.227223+00:00
Z9o5ZK0yEemigYc7qJtOMw,jgraPEon,https://europepmc.org/articles/PMC5395742/,hepatitis B virus (HBV) infection,risk factor for HCC in China is ,", although hepatitis C virus inf",TextQuoteSelector,TextPositionSelector,58473,58506,WS_DS,no,WS_DS,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:12:41.086622+00:00
YvK0Vq00Eem_Oju5qdD1vA,jgraPEon,https://europepmc.org/articles/PMC5395742/, glioblastoma,sed the invasive activity of the, cells [44]. Inactivation of c-M,TextQuoteSelector,TextPositionSelector,56708,56721,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:26:51.727895+00:00
YNHMWK0zEemVOIu81mOSKA,jgraPEon,https://europepmc.org/articles/PMC5395742/,protein A,ith the indicated antibodies on ,/G beads (Life Technologies) ove,TextQuoteSelector,TextPositionSelector,27168,27177,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:19:38.748173+00:00
XbmXmK00EemwhBtan4GnyQ,jgraPEon,https://europepmc.org/articles/PMC5395742/,vascularization,be involved in tumor growth and ,. Previous reports showed that t,TextQuoteSelector,TextPositionSelector,56586,56601,WT_DS,no,[WT_DS],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:26:43.107024+00:00
WygeVLRlEemQuEcAIuBUsQ,jgraPEon,https://europepmc.org/articles/PMC5395742/,polymerase,ISH) and quantitative real-time , chain reaction (qRT-PCR) analys,TextQuoteSelector,TextPositionSelector,10568,10578,MIS_GP,yes,[MIS_GP][ALL],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T14:05:02.172876+00:00
W57I5K0zEemZaj_NFytmyw,jgraPEon,https://europepmc.org/articles/PMC5395742/, streptavidin,iotinylated RNAs were mixed with, agarose beads (Life Technologie,TextQuoteSelector,TextPositionSelector,24921,24934,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:19:30.036322+00:00
VuhCJq0zEemJbgfS0ABO4w,jgraPEon,https://europepmc.org/articles/PMC5395742/, DNase I,and then treated with RNase-free, (Roche) and 0.2 M EDTA to stop ,TextQuoteSelector,TextPositionSelector,24834,24842,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:19:22.203780+00:00
Vb8ryq00EemaE3vvOzciAw,jgraPEon,https://europepmc.org/articles/PMC5395742/,NF2,o and ubiquitinating LATS1/2 in ,-mutant tumors in the nucleus [3,TextQuoteSelector,TextPositionSelector,55224,55227,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:26:29.714379+00:00
VIuaxK0yEemwfRf_rc56qw,jgraPEon,https://europepmc.org/articles/PMC5395742/, lung metastases,showing the number and volume of, in each group (n=6); **P<0. 01 ,TextQuoteSelector,TextPositionSelector,35425,35441,WT_DS,yes,[WT_DS][ALL],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:12:08.671548+00:00
UmNyXK0zEem4L8tnhgQt8g,jgraPEon,https://europepmc.org/articles/PMC5395742/,T7 RNA polymerase,in RNA Labeling Mix (Roche) and , (Roche) and then treated with R,TextQuoteSelector,TextPositionSelector,24776,24793,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:19:14.580730+00:00
TNnJXq0yEem4KzucsD1xbw,jgraPEon,https://europepmc.org/articles/PMC5395742/,RNase,e (Roche) and then treated with ,-free DNase I (Roche) and 0.2 M ,TextQuoteSelector,TextPositionSelector,24824,24829,CRT_GP,yes,[CRT_GP][ALL],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:11:55.875910+00:00
TAjCNq0zEem4M3_cJ2ddFw,jgraPEon,https://europepmc.org/articles/PMC5395742/,protease ,ed in lysis buffer containing a ,inhibitor cocktail and RNase inh,TextQuoteSelector,TextPositionSelector,24076,24085,WS_GP,no,WS_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:19:03.783712+00:00
T5YwuK00Eemo4w8Rgf4ugg,jgraPEon,https://europepmc.org/articles/PMC5395742/,Notch,"se/AKT, Hedgehog, Jak/Stat, and ", pathways [40]. A previous study,TextQuoteSelector,TextPositionSelector,54362,54367,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:26:19.249942+00:00
Sbvq3q00EemXk3cdQm09WQ,jgraPEon,https://europepmc.org/articles/PMC5395742/,Stat,", PI3-kinase/AKT, Hedgehog, Jak/",", and Notch pathways [40]. A pre",TextQuoteSelector,TextPositionSelector,54352,54356,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:26:09.652053+00:00
Rj5kYK0yEemJZjN11xb0eA,jgraPEon,https://europepmc.org/articles/PMC5395742/,E2F1,"tor of apoptosis 1 (diap1), and ",", were significantly reduced. In",TextQuoteSelector,TextPositionSelector,45336,45340,CRT_GP,yes,[CRT_GP][ALL],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:11:44.778935+00:00
Rg_e5q0zEemsCyvtrHg9WQ,jgraPEon,https://europepmc.org/articles/PMC5395742/,RNA-Binding Protein ,s performed using the Magna RIP ,Immunoprecipitation Kit (Millipo,TextQuoteSelector,TextPositionSelector,23898,23918,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:18:53.925475+00:00
RDl3hK00EemR8S94L2OIvw,jgraPEon,https://europepmc.org/articles/PMC5395742/,PI3-kinase,"s the TGFβ/SMAD, WNT/β-catenin, ","/AKT, Hedgehog, Jak/Stat, and No",TextQuoteSelector,TextPositionSelector,54322,54332,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:26:00.305741+00:00
QjVBBrQLEem22lsc2t42iA,jgraPEon,https://europepmc.org/articles/PMC5395742/,LATS1 and pYAPS127 were significantly depressed in tumors ,d that the expression levels of ,compared with adjacent tissues. ,TextQuoteSelector,TextPositionSelector,63446,63504,YGD,no,YGD,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:20:05.558719+00:00
QNPUbq0zEemVN6-r-cOuyQ,jgraPEon,https://europepmc.org/articles/PMC5395742/,β-actin,plified as an internal control. , and U6 were used as cytoplasmic,TextQuoteSelector,TextPositionSelector,23630,23637,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:18:45.040565+00:00
PkFH0q0yEemLBTsRq-JQoQ,jgraPEon,https://europepmc.org/articles/PMC5395742/,E3 ubiquitin ligase, mass spectrometry detected the ," CUL4A, and subsequent Western b",TextQuoteSelector,TextPositionSelector,37691,37710,WS_GP,yes,[WS_GP][ALL],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:11:31.411900+00:00
Pbx82K0xEem6CQ9dflWRCA,jgraPEon,https://europepmc.org/articles/PMC5395742/,HCC,groundHepatocellular carcinoma (,) is one of the most common caus,TextQuoteSelector,TextPositionSelector,12636,12639,MIS_DS,yes,[MIS_DS][ALL],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:04:20.932158+00:00
Pbm_qLQLEemuv7-vIdQyrA,jgraPEon,https://europepmc.org/articles/PMC5395742/,"CUL4A, suggesting that it may serve as a tumor suppressor and prognostic biomarker in HCC",po kinase signaling by blocking ,".Go to:Additional files
Addition",TextQuoteSelector,TextPositionSelector,60631,60720,YGD,no,YGD,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:19:58.167158+00:00
PT_EPLRlEem4QNOL1rNmDw,jgraPEon,https://europepmc.org/articles/PMC5395742/, MEK,increases resistance to RAF- and,-targeted cancer therapies [41].,TextQuoteSelector,TextPositionSelector,54439,54443,MIS_GP,no,MIS_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T14:04:12.108665+00:00
Oi5CCrQLEemlmfskcvr1yQ,jgraPEon,https://europepmc.org/articles/PMC5395742/,HCC by inhibiting CUL4A-mediated ubiquitination of LATS1,4 suppressed the progression of ,. Hippo kinase signaling is high,TextQuoteSelector,TextPositionSelector,59174,59230,YGD,no,YGD,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:19:52.199487+00:00
OYCwJK0zEembImNs4vdo7A,jgraPEon,https://europepmc.org/articles/PMC5395742/,GAPDH,ucibility of the results. Human , gene was amplified as an intern,TextQuoteSelector,TextPositionSelector,23581,23586,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:18:32.914757+00:00
NfHX7LQLEemjnnevb61exQ,jgraPEon,https://europepmc.org/articles/PMC5395742/,LATS1 in HCC,of lncRNAs in the regulation of ,". Thus, this lncRNA may offer a ",TextQuoteSelector,TextPositionSelector,58259,58271,YGD,no,YGD,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:19:45.101507+00:00
MyabUq00Eem_NsM_nmjXMg,jgraPEon,https://europepmc.org/articles/PMC5395742/,Hippo kinase ,ber of studies confirm that the ,"signaling, which is critical for",TextQuoteSelector,TextPositionSelector,54014,54027,MIS_GP,yes,[MIS_GP][ALL],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:25:31.548956+00:00
MmGwAK0yEemS_edXva9vuA,jgraPEon,https://europepmc.org/articles/PMC5395742/,Ubiquitin,on (IP) and ubiquitination assay,", LATS1, and uc.134 plasmids wer",TextQuoteSelector,TextPositionSelector,26882,26891,CRT_GP,yes,[CRT_GP][ALL],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:11:11.403821+00:00
MiHpBLQLEemHip8Q5929tQ,jgraPEon,https://europepmc.org/articles/PMC5395742/,"E2F1, which plays key roles in cell cycle progression and cell differentiation in HCC",ion of the cell cycle regulator ," [48, 49]. We performed microarr",TextQuoteSelector,TextPositionSelector,57301,57386,YGD,no,YGD,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:19:38.679763+00:00
M1rRFq0zEemkBotfP6Jizw,jgraPEon,https://europepmc.org/articles/PMC5395742/, reverse transcriptase, total RNA was performed using a, cDNA synthesis kit (Takara). Th,TextQuoteSelector,TextPositionSelector,23099,23121,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:18:22.507617+00:00
Ll_p2LQLEemzNEdKq0KoHw,jgraPEon,https://europepmc.org/articles/PMC5395742/,Myc via interaction with c-Abl in HCC ,e transcriptional activity of c-,[45]. diap1 directly binds to an,TextQuoteSelector,TextPositionSelector,56897,56935,YGD,no,YGD,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:19:32.298641+00:00
KUKHgLQLEem78iv1_ejEIg,jgraPEon,https://europepmc.org/articles/PMC5395742/,LATS1/2 in NF2-mutant tumors,y binding to and ubiquitinating ," in the nucleus [37]. However, t",TextQuoteSelector,TextPositionSelector,55213,55241,YGD,no,YGD,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:19:23.903325+00:00
KC-A_K0zEemwgJ8Rl982mg,jgraPEon,https://europepmc.org/articles/PMC5395742/, animal ,red significant.In vivo modelAll,studies were performed with the ,TextQuoteSelector,TextPositionSelector,21332,21340,MIS_OG,no,MIS_OG,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:18:03.741130+00:00
JYx5jrQLEemAZLNl5RrHvA,jgraPEon,https://europepmc.org/articles/PMC5395742/,LATS1 is a core kinase of Hippo kinase signaling pathway and plays important roles in tumor,"er, the serine/threonine kinase "," proliferation, apoptosis, and s",TextQuoteSelector,TextPositionSelector,54526,54617,YGD,no,YGD,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:19:17.583005+00:00
JMA2Pq02EemZ0N-4aj2kYA,jgraPEon,https://europepmc.org/articles/PMC5395742/,RNA polymerase,ed ubiquitin protein ligase and , activity compared with the nega,TextQuoteSelector,TextPositionSelector,41777,41791,MIS_GP,no,MIS_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:39:26.488104+00:00
JI4Vqq0xEemZXReo2rrRzA,jgraPEon,https://europepmc.org/articles/PMC5395742/,HCC,groundHepatocellular carcinoma (,) is one of the most common mali,TextQuoteSelector,TextPositionSelector,9815,9818,"WT_GP,DS",yes,[WT_GP][DS][ALL],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:03:38.479172+00:00
Ijc0_K0yEemaqNt_wvLtLQ,jgraPEon,https://europepmc.org/articles/PMC5395742/,cancers,f)CUL4A is amplified in various ,", which suggests its role in reg",TextQuoteSelector,TextPositionSelector,40409,40416,CRT_DS,yes,[CRT_DS][ALL],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:10:44.344459+00:00
Ho1gYrQLEemlmEPPmgJUtg,jgraPEon,https://europepmc.org/articles/PMC5395742/,CUL4A-Hippo axis may offer a promising approach for the treatment of HCC,"naling. Thus, the lncRNA uc.134-"," (Fig. 6e).
Go to:DiscussionHCC ",TextQuoteSelector,TextPositionSelector,51192,51264,YGD,no,YGD,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:19:05.896868+00:00
HKvqFq01Eem4QYfoiiNnFw,jgraPEon,https://europepmc.org/articles/PMC5395742/,LAST1,"ive relationships among uc.134, ",", and pYAPS127 in 90 paraffin-em",TextQuoteSelector,TextPositionSelector,60475,60480,MIS_GP,no,MIS_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:32:03.294396+00:00
GlIeFrQLEem5s5PfgrekWg,jgraPEon,https://europepmc.org/articles/PMC5395742/, LATS1 and pYAPS127 are reduced in the HCC,rly show that the expressions of, tissues compared with the adjac,TextQuoteSelector,TextPositionSelector,50429,50471,YGD,no,YGD,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:18:58.836933+00:00
GWILtq00EemLFEf5JpOebg,jgraPEon,https://europepmc.org/articles/PMC5395742/,YAP ,A previous study confirmed that ,increases resistance to RAF- and,TextQuoteSelector,TextPositionSelector,54415,54419,MIS_GP,yes,[MIS_GP][ALL],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:24:48.402956+00:00
Fxh42rQLEemE54dtsohdCA,jgraPEon,https://europepmc.org/articles/PMC5395742/,HCC patients with low LATS1 ,The median survival time of the ,"expression was 16 months, which ",TextQuoteSelector,TextPositionSelector,49641,49669,YGD,no,YGD,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:18:53.355246+00:00
F_PFCq0yEemPwkc_lZbSXQ,jgraPEon,https://europepmc.org/articles/PMC5395742/,hepatocellular carcinoma,A novel lncRNA uc.134 represses , progression by inhibiting CUL4A,TextQuoteSelector,TextPositionSelector,7041,7065,CRT_DS,yes,[CRT_DS][ALL],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:10:27.055387+00:00
FM-IHLRVEemGE_P2Z0MSVg,jgraPEon,https://europepmc.org/articles/PMC5395742/,tumor,"over, MALAT1 is associated with ", metastasis and can predict recu,TextQuoteSelector,TextPositionSelector,13817,13822,WS_DS,no,WS_DS,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T12:08:32.269665+00:00
EfgTeq00Eemo7OP1Cq5tIA,jgraPEon,https://europepmc.org/articles/PMC5395742/,RAF,hat YAP increases resistance to ,- and MEK-targeted cancer therap,TextQuoteSelector,TextPositionSelector,54443,54446,MIS_GP,no,MIS_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:24:35.984495+00:00
EaCUALQLEem-pRtwkAegUg,jgraPEon,https://europepmc.org/articles/PMC5395742/,LATS1 and pYAPS127 levels in HCC,sion positively correlates with , patient samplesWe studied corre,TextQuoteSelector,TextPositionSelector,48965,48997,YGD,no,YGD,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:18:44.297973+00:00
E8aGrrQLEem0EXfyXFkuyA,jgraPEon,https://europepmc.org/articles/PMC5395742/,LATS1 was significantly downregulated in the tumor,ang Hospital. The expression of , tissues compared with the adjac,TextQuoteSelector,TextPositionSelector,49322,49372,YGD,no,YGD,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:18:47.915402+00:00
DQZRMK0yEemmJ5vQbvhufA,jgraPEon,https://europepmc.org/articles/PMC5395742/,diap1,phila inhibitor of apoptosis 1 (,"), and E2F1, were significantly ",TextQuoteSelector,TextPositionSelector,45324,45329,CRT_GP,yes,[CRT_GP][ALL],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:10:08.525133+00:00
CnCKlq01EemQvM_cUdOiYQ,jgraPEon,https://europepmc.org/articles/PMC5395742/,TEAD ,"transcription, YAP binds to the ",complex and elevates the levels ,TextQuoteSelector,TextPositionSelector,56378,56383,MIS_GP,no,MIS_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:31:32.807196+00:00
Ceep8q00Eem6EaOcd2VW1g,jgraPEon,https://europepmc.org/articles/PMC5395742/,Hedgehog," WNT/β-catenin, PI3-kinase/AKT, ",", Jak/Stat, and Notch pathways [",TextQuoteSelector,TextPositionSelector,54338,54346,MIS_GP,no,MIS_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:24:22.445557+00:00
CCDY_rQLEem0EC8cHyES1A,jgraPEon,https://europepmc.org/articles/PMC5395742/, CUL4A overexpression abrogated the uc.134-mediated repression HCC ,al function analysis showed that,"cell proliferation and invasion,",TextQuoteSelector,TextPositionSelector,47445,47512,YGD,no,YGD,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:18:28.361678+00:00
C3wvRLQLEemPtp-IVR93kw,jgraPEon,https://europepmc.org/articles/PMC5395742/,HCC by blocking CUL4A nuclear export to ubiquitinate LATS1,"on, invasion, and metastasis of ", and increasing YAPS127 phosphor,TextQuoteSelector,TextPositionSelector,47747,47805,YGD,no,YGD,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:18:33.979553+00:00
BqRmzK00EemVPSN8MOxEdQ,jgraPEon,https://europepmc.org/articles/PMC5395742/,AKT,"SMAD, WNT/β-catenin, PI3-kinase/",", Hedgehog, Jak/Stat, and Notch ",TextQuoteSelector,TextPositionSelector,54333,54336,MIS_GP,no,MIS_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:24:16.736435+00:00
BeR99K0zEemZwOcuIMcnbA,jgraPEon,https://europepmc.org/articles/PMC5395742/, animals,elines for the use of laboratory,. For the subcutaneously injecte,TextQuoteSelector,TextPositionSelector,21704,21712,CRT_OG,no,CRT_OG,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:17:06.088915+00:00
BRZVdrQLEem476_OIg6-_w,jgraPEon,https://europepmc.org/articles/PMC5395742/, CUL4A to overcome the uc.134-mediated activation of Hippo kinase signaling in HCC, We then assessed the ability of," cells. Notably, Western blottin",TextQuoteSelector,TextPositionSelector,46999,47081,YGD,no,YGD,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:18:23.151204+00:00
AwK7hq00Eem-NDMIxnYgtw,jgraPEon,https://europepmc.org/articles/PMC5395742/,WNT,"athways, such as the TGFβ/SMAD, ","/β-catenin, PI3-kinase/AKT, Hedg",TextQuoteSelector,TextPositionSelector,54307,54310,MIS_GP,no,MIS_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:24:10.720239+00:00
AblLXrQLEem6I7vgXAVNFg,jgraPEon,https://europepmc.org/articles/PMC5395742/,HCC proliferation and metastasis via the uc.134-CUL4A,protein.LncRNA uc.134 represses ,-Hippo axisA Western blot analys,TextQuoteSelector,TextPositionSelector,46690,46743,YGD,no,YGD,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:18:17.495112+00:00
AGk0YK0yEemZtzdT1WUjxA,jgraPEon,https://europepmc.org/articles/PMC5395742/,drosophila inhibitor of apoptosis 1,"enic inducer 61 (CYR61), c-Myc, "," (diap1), and E2F1, were signifi",TextQuoteSelector,TextPositionSelector,45287,45322,WS_GP,no,WS_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:09:47.556626+00:00
AAB3yq00EemsDHezoxCzZQ,jgraPEon,https://europepmc.org/articles/PMC5395742/,SMAD,"ling pathways, such as the TGFβ/",", WNT/β-catenin, PI3-kinase/AKT,",TextQuoteSelector,TextPositionSelector,54301,54305,MIS_GP,no,MIS_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:24:05.963008+00:00
A1z8RK01EemwiEuM5WkbYQ,jgraPEon,https://europepmc.org/articles/PMC5395742/,cullin ,he 400–671 aa region encoding a ,homolog was cloned into pcDNA3.1,TextQuoteSelector,TextPositionSelector,25800,25807,MIS_GP,yes,[MIS_GP][ALL],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:31:21.066930+00:00
9txz3K00EemR9u8Iz_etSA,jgraPEon,https://europepmc.org/articles/PMC5395742/,E3 ligase,ch showed that uc.134 bound the , CUL4A. Protein domain mapping a,TextQuoteSelector,TextPositionSelector,55421,55430,MIS_GP,yes,[MIS_GP][ALL],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:30:59.821148+00:00
9MOO2K0zEemUCcMNpNTJeA,jgraPEon,https://europepmc.org/articles/PMC5395742/,β-catenin,"ays, such as the TGFβ/SMAD, WNT/",", PI3-kinase/AKT, Hedgehog, Jak/",TextQuoteSelector,TextPositionSelector,54311,54320,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:23:46.694555+00:00
8j6Dwq0xEemokMeCVYQaUQ,jgraPEon,https://europepmc.org/articles/PMC5395742/,c-Myc," angiogenic inducer 61 (CYR61), ",", drosophila inhibitor of apopto",TextQuoteSelector,TextPositionSelector,45280,45285,CRT_GP,yes,[CRT_GP][ALL],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:09:23.613882+00:00
8USomrQKEemE5lvjC1mwWw,jgraPEon,https://europepmc.org/articles/PMC5395742/, HCC progression by inhibiting the CUL4A-mediated ubiquitination of LATS1,he novel lncRNA uc.134 represses, and increasing pYAPS127 express,TextQuoteSelector,TextPositionSelector,16688,16761,YGD,no,YGD,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:17:49.867528+00:00
7pg8Fq0zEemqmjutZZvAdw,jgraPEon,https://europepmc.org/articles/PMC5395742/, mammals,gnaling pathway are conserved in, and have a complex network of c,TextQuoteSelector,TextPositionSelector,54194,54202,CRT_OG,no,CRT_OG,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:23:36.496118+00:00
7nknCLQKEemsmBNUoBeE6Q,jgraPEon,https://europepmc.org/articles/PMC5395742/,HCC cell proliferation and invasion by inhibiting CUL4A to ubiquitinate LATS1,expression of uc.134 suppresses , and increasing pYAPS127 express,TextQuoteSelector,TextPositionSelector,16289,16366,YGD,no,YGD,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:17:45.096421+00:00
7SygFq0yEemkA1MoILCWhQ,jgraPEon,https://europepmc.org/articles/PMC5395742/,serine/threonine-protein kinase LATS1 ,"is. By phosphorylating YAP, the ",inhibits the translocation of YA,TextQuoteSelector,TextPositionSelector,15172,15210,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:16:24.575427+00:00
7P7EQK01Eemo8_9vQYJcKA,jgraPEon,https://europepmc.org/articles/PMC5395742/,CUL4A,racts with CUL4A to form uc.134-," RNPs.
Open in a separate window",TextQuoteSelector,TextPositionSelector,39342,39347,MIS_GP,yes,[MIS_GP][ALL],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:37:52.840193+00:00
7IqKUq0xEemnHJsW12nogg,jgraPEon,https://europepmc.org/articles/PMC5395742/,CYR61,ine-rich angiogenic inducer 61 (,"), c-Myc, drosophila inhibitor o",TextQuoteSelector,TextPositionSelector,45272,45277,CRT_GP,yes,[CRT_GP][ALL],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:09:14.171887+00:00
6Th7fLQKEemKtBfgyMSQIg,jgraPEon,https://europepmc.org/articles/PMC5395742/, hepatocellular carcinoma progression by inhibiting the CUL4A-mediated ubiquitination of LATS1," novel lncRNA, uc.134, represses", and increasing YAPS127 phosphor,TextQuoteSelector,TextPositionSelector,12078,12172,YGD,no,YGD,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:17:36.396357+00:00
6FvBsK0zEemaDaO77IPrZw,jgraPEon,https://europepmc.org/articles/PMC5395742/, tumor progression ,"signaling, which is critical for","and invasion, is inactivated in ",TextQuoteSelector,TextPositionSelector,54059,54078,WT_DS,no,[WT_DS],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:23:26.067349+00:00
5ntrzK0xEemx2LubX8_QsA,jgraPEon,https://europepmc.org/articles/PMC5395742/,CCK8 ,urves of HCC cells generated by ,proliferation analysis. The mean,TextQuoteSelector,TextPositionSelector,62223,62228,WT_GP,yes,[WT_GP][ALL],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:09:03.883873+00:00
5bbYSq00EemYj38u9dPPhQ,jgraPEon,https://europepmc.org/articles/PMC5395742/,DICER," CUL4A including p53, p21, p27, ",", and LATS1 [32]. Previous studi",TextQuoteSelector,TextPositionSelector,40625,40630,MIS_GP,no,MIS_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:30:31.303046+00:00
5TiPvLQKEem6Is-vUhJVQg,jgraPEon,https://europepmc.org/articles/PMC5395742/,hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1,A novel lncRNA uc.134 represses ,"Wen Ni,1 Yuqin Zhang,1 Zetao Zha",TextQuoteSelector,TextPositionSelector,7041,7130,YGD,no,YGD,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:17:29.559204+00:00
5FzkAK0yEembH9_TAz4GRg,jgraPEon,https://europepmc.org/articles/PMC5395742/,NF90,tastases via the degradation of ," [19], and MEG3 is a predictive ",TextQuoteSelector,TextPositionSelector,14162,14166,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:16:09.936671+00:00
4g0AgK0zEem-M2dVFXBBjQ,jgraPEon,https://europepmc.org/articles/PMC5395742/,genetic disease,h HCC.Cancer is fundamentally a , with numerous alterations in DN,TextQuoteSelector,TextPositionSelector,53005,53020,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:23:15.561093+00:00
3CypYrQKEemR9QvvK6WqRw,jgraPEon,https://europepmc.org/articles/PMC5395742/,LATS1 and pYAPS127 expression levels in HCC ,panels: HE staining. Figure S7. ,"specimens. (A, B) IHC analysis i",TextQuoteSelector,TextPositionSelector,63301,63345,NGD,no,NGD,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:17:14.481916+00:00
36fCaK0yEemmKseWEK22pQ,jgraPEon,https://europepmc.org/articles/PMC5395742/,UFC1,"antation [16, 17]. Furthermore, ", promotes HCC cell proliferation,TextQuoteSelector,TextPositionSelector,13925,13929,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:16:01.816118+00:00
35Ox3q0xEemT_f-pM2k7bA,jgraPEon,https://europepmc.org/articles/PMC5395742/,Lung metastasis ,ntrol cells. (n=5) *P<0.05. (F) ,model generated by injecting can,TextQuoteSelector,TextPositionSelector,62980,62996,WT_DS,yes,[WT_DS][ALL],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:08:52.394360+00:00
2zABmq0zEemJcXPiipy9Qg,jgraPEon,https://europepmc.org/articles/PMC5395742/,carcinomas,and differentially expressed in ,". Here, we used lncRNA microarra",TextQuoteSelector,TextPositionSelector,51983,51993,CRT_DS,no,CRT_DS,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:23:04.050973+00:00
2THL3K0xEemPv5sG8HvBnw,jgraPEon,https://europepmc.org/articles/PMC5395742/,Myc,EK293T cells. d IB detection of ,-tagged CUL4A (WT versus domain ,TextQuoteSelector,TextPositionSelector,40058,40061,CRT_GP,yes,[CRT_GP][ALL],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:08:41.844903+00:00
1stZ8K00Eemfegu4gTZAgA,jgraPEon,https://europepmc.org/articles/PMC5395742/,EGFP,at the stable overexpression of ,-LV-uc.134 (Additional file 5: F,TextQuoteSelector,TextPositionSelector,33672,33676,MIS_GP,yes,[MIS_GP][ALL],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:30:06.094981+00:00
1L0P9q0zEemmNvvkq4jlbg,jgraPEon,https://europepmc.org/articles/PMC5395742/, rats,"nserved across humans, mice, and",", so-called ultraconserved regio",TextQuoteSelector,TextPositionSelector,51831,51836,CRT_OG,no,CRT_OG,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:22:53.226593+00:00
1JUBhrQKEem685dXvReWvA,jgraPEon,https://europepmc.org/articles/PMC5395742/,"HCC cells with plasmids expressing YAP and those expressing uc.134, the decrease in the mRNA level of CYR61, c-Myc, diap1, and E2F1 ","ion, when we co-transfected the ","was reversed by YAP, indicating ",TextQuoteSelector,TextPositionSelector,57582,57714,NGD,no,NGD,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:17:01.776423+00:00
1FvIyK0yEemwKcu99g5O5Q,jgraPEon,https://europepmc.org/articles/PMC5395742/,MALAT1,"d metastasis [13–15]. Moreover, ", is associated with tumor metast,TextQuoteSelector,TextPositionSelector,13804,13810,CRT_GP,no,CRT_GP,,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:15:43.238294+00:00
0xf_bq0xEemUT0PBGqteBw,jgraPEon,https://europepmc.org/articles/PMC5395742/,nude mice, inoculated subcutaneously into ,", and the HCCLM3 cell line was e",TextQuoteSelector,TextPositionSelector,28564,28573,CRT_OG,yes,[CRT_OG][ALL],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:08:31.325695+00:00
-1l3uK0yEemwKuOt_KeNnw,jgraPEon,https://europepmc.org/articles/PMC5395742/,HRP,on with horseradish peroxidase (,)-conjugated anti-DIG antibodies,TextQuoteSelector,TextPositionSelector,20099,20102,WT_GP,no,[WT_GP],,acct:farheen.s@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-23T10:16:48.561442+00:00
